Cite

HARVARD Citation

    Yu, Y. et al. (2021). Impact of effective dose to immune cells (EDIC) on lymphocyte nadir and survival in limited-stage SCLC. Radiotherapy and oncology. pp. 26-33. [Online]. 
  
Back to record